pharmaceutical company germany
Venus Pharma GmbH is a renowned pharmaceutical company based in Germany, known for its dedication to delivering high-quality healthcare solutions. With a strong global presence, the company specializes in the development, manufacturing, and distribution of a wide range of pharmaceutical products. Venus Pharma is committed to innovation, safety, and excellence, ensuring that every product meets stringent international standards. Its mission is to improve patient health outcomes through reliable and effective medications. Trusted by healthcare professionals worldwide, Venus Pharma continues to g
pharmaceutical company germany
E N D
Presentation Transcript
Venus Pharma GmbH: Your European Pharma Partner With two decades of competence, Venus Pharma GmbH has been a trusted name in the pharmaceutical industry. We offer an extensive product portfolio backed by assured quality and timely delivery.
Our Core Principles Uncompromising Quality Extensive Product Basket Timely Deliveries Rigorous quality control measures ensure every product meets the highest safety and efficacy standards. A diverse range of pharmaceutical products caters to various therapeutic areas and market segments. Efficient supply chain management prioritizes prompt order processing and dispatch.
Company History: Key Milestones Explore the significant achievements and growth of Venus Pharma GmbH throughout the years.
Milestones: Market Expansion & Product Leadership 2019: Market Share 2013: UK Market Attained 50% market share in Italy. Captured 33% of the UK market share for Gemcitabine. 2015: Flagship Product 2012: Portfolio Launch Meropenem secured 50% market share in Germany. Launched Anti-Cancer & Antibiotics portfolios in Germany & the UK.
Milestones: Global Reach & Certifications 2009: Middle East Expansion 2006: German Entry Entered the German pharmaceutical space with the acquisition of a manufacturing facility at Werne, transforming it into Venus Pharma GmbH (VPG). Expanded footprints in prime Middle Eastern markets, focusing on Syria. 2007: EU-GMP Certification Achieved first EU-GMP certification for the Indian manufacturing unit.
Milestones: Innovation & Recognition 2024: Marketing Authorisations 2021: Global Presence VPG now holds 138+ Marketing Authorisations across 20 countries. Research presented at ESCMID, World Microbe Forum. Supplied 4 million vials of Ceftriaxone to Iraq. Launched Meropenem in UAE and Bahrain. 2022: Research & Speaking 2020: Pioneering Meropenem Research presented at ESCMID & ASM Microbe Conference. Invited speaker at Indo-German Workshop on AMR. First to introduce Meropenem 2000 mg. Received WHO Prequalification for Meropenem.
Building Business Models 2018: VPG Hub Established VPG as a hub for multiple business models, including Tech Transfer, In-Licensing, Out-Licensing, Product Development, Site Variation, Packaging, Warehousing, and Batch Release. 2016: EU Market Successfully completed 10 years in the EU market, with intellectual capital as a primary business driver.
Stay Updated with Our Journey Explore the recent highlights and updates from our organization. Catch up on our latest achievements and milestones through our blog posts. Your European Pharma Partner – Venus Pharma GMBH What Is a Marketing Authorization Holder (MAH) and Why It Matters? Dynamic Health & Safety Practices Being healthy and staying safe are two BIG blessings that make humans actually capable. In the rapidly evolving pharmaceutical industry, partnering with an experienced company is crucial. The MAH role is central to ensuring medicines are safe, effective, and compliant with legal requirements. By Parveen Anttal | February 17, 2025 By Ankush Sharma | February 21, 2025 By Ankush Sharma | July 9, 2025
What Our Partners Say "Venus Remedies is a company with many years of worldwide experience, with a factory dedicated to the manufacture of medicines for export. It is a company with high-quality standards, which has various certifications from European countries." "I highly value the quality of Venus products, the speed of delivery times, the ability they have to serve us efficiently, almost without errors, and also the particularity of negotiation management as strategic partners that allows us to have a good result within our marketing process." Carolina SerratoCommercial Manager, Latin America, Alpharma Ronald FloreSupply Chain Manager, Grupo CORPOL